StonvexLoading…
StonvexStonvexStonvexCore line items from AMPY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $263.36M | $294.68M | $307.60M | $458.46M |
Operating Income | $76.94M | $30.42M | $76.22M | $71.99M |
Net Income | $43.97M | $12.95M | $392.75M | $57.88M |
EPS (Diluted) | $1.03 | $0.31 | $9.63 | $1.44 |
Total Assets | $600.90M | $747.08M | $737.67M | $459.48M |
Total Liabilities | $142.18M | $338.16M | $346.64M | $464.04M |
Cash & Equivalents | $60.67M | Not available | $20.75M | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 40.72M | 39.80M | 39.15M | 38.46M |